AUKUS as a Balance of Power Strategy in Confronting PRC in the Indo-Pacific: Perspectives from the United States, the United Kingdom, and Australia
Vestnik Tomskogo gosudarstvennogo universiteta. Istoriya · 2026 · (99) · 118-125
DOI: 10.17223/19988613/99/13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vestnik Tomskogo gosudarstvennogo universiteta. Istoriya, 2026. Verfasst von Dzaka Ashriel Faris und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This study analyzes AUKUS as a trilateral balance of power strategy countering People’s Republic of China rise in the Indo-Pacific. Using qualitative document analysis, it examines security architecture evolution from Five Eyes to AUKUS in September 2021. The US pursues integrated deterrence, the UK realizes “Global Britain,” and Australia counters the “arc of autocracy.” Nuclear-powered submarine technology transfer is the key balance-of-power instrument. While AUKUS strengthens trilateral deterrence, it creates security dilemmas and challenges ASEAN centrality. The authors declare no conflicts of interests.
Zitieren
APA
Faris, D. A., & Timoshenko, A. G. (2026). AUKUS as a Balance of Power Strategy in Confronting PRC in the Indo-Pacific: Perspectives from the United States, the United Kingdom, and Australia. Vestnik Tomskogo gosudarstvennogo universiteta. Istoriya, 118-125. https://doi.org/10.17223/19988613/99/13
Vancouver
Faris DA, Timoshenko AG. AUKUS as a Balance of Power Strategy in Confronting PRC in the Indo-Pacific: Perspectives from the United States, the United Kingdom, and Australia. Vestnik Tomskogo gosudarstvennogo universiteta. Istoriya. 2026:118-125. doi:10.17223/19988613/99/13
BibTeX
@article{Faris2026,
author = {Faris, Dzaka Ashriel and Timoshenko, Alexey G.},
title = {AUKUS as a Balance of Power Strategy in Confronting PRC in the Indo-Pacific: Perspectives from the United States, the United Kingdom, and Australia},
journal = {Vestnik Tomskogo gosudarstvennogo universiteta. Istoriya},
year = {2026},
number = {99},
pages = {118--125},
doi = {10.17223/19988613/99/13}
}
EUVIMED